Medicare Enrolled

Dr. Kathreen Kraus, M.D.

Infectious Disease · Homestead, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
950 N KROME AVE, Homestead, FL 33030
3055761234
In practice since 2009 (16 years)
NPI: 1740414069 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kraus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kraus? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kraus

Dr. Kathreen Kraus is an infectious disease in Homestead, FL, with 16 years in practice. Based on federal Medicare data, Dr. Kraus performed 118 Medicare services across 74 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kraus received a total of $10,478 from 18 pharmaceutical and/or device companies across 189 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kraus is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ 118 Medicare services$ $10,478 industry payments

Medicare Practice Summary

Medicare Utilization ↗
118
Medicare services
Bottom 11% in FL for infectious disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
74
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity83$100$221
Initial hospital admission, high complexity35$148$424
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,478
Total received (2018-2024)
Avg $1,497/year across 7 years
Top 14% in FL for infectious disease
18
Companies
189
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,410 (51.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,854 (46.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$214 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$254
2023
$469
2022
$589
2021
$575
2020
$393
2019
$6,724
2018
$1,475

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$6,619
ViiV Healthcare Company
$1,244
Janssen Biotech, Inc.
$508
Merck Sharp & Dohme Corporation
$488
Allergan Inc.
$284
Esperion Therapeutics, Inc.
$249
Janssen Products, LP
$214
GlaxoSmithKline, LLC.
$139
Melinta Therapeutics, LLC
$125
Insmed, Inc.
$117
Novartis Pharmaceuticals Corporation
$115
Merck Sharp & Dohme LLC
$114
EMD Serono, Inc.
$102
AstraZeneca Pharmaceuticals LP
$102
Mylan Pharmaceuticals Inc.
$16
Napo Pharmaceuticals Inc
$15
Theratechnologies Inc.
$15
Dynavax Technologies Corporation
$11
Top 3 companies account for 79.9% of total payments
Associated products mentioned in payments ›
APRETUDE · AVYCAZ · Arikayce · BEXSERO · Biktarvy · CABENUVA · DELSTRIGO · DOVATO · Descovy · ENTRESTO · Epclusa · FARXIGA · Heplisav-B · ISENTRESS · JULUCA · Mytesi · NEXLIZET · PIFELTRO · PREZCOBIX · RUKOBIA · SEROSTIM · SHINGRIX · SYMTUZA · Serostim · Symfi · Symtuza · TRIUMEQ · TROGARZO · Vabomere · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (52%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $8,880 per 100 Medicare services performed
Looking for a infectious disease in Homestead?
Compare infectious diseases in the Homestead area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious Diseases within 10 mi
40
Per 100K population
1.5
County median income
$68,694
Nearest hospital
HOMESTEAD HOSPITAL
6.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kraus is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 14%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kraus experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Kraus performed 83 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kraus receive payments from pharmaceutical companies?
Yes. Dr. Kraus received a total of $10,478 from 18 companies across 189 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kraus's costs compare to other infectious diseases in Homestead?
Dr. Kraus's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kraus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →